Loading…
Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population
Background IL-4 is known to present abnormal expression in thyroid tumors and SNPs in the IL-4 and its receptor IL-4R genes are associated to risk and mortality of various types of cancer. Methods In order to evaluate their role in differentiated thyroid cancer (DTC), we investigated genetic frequen...
Saved in:
Published in: | Endocrine 2021-05, Vol.72 (2), p.470-478 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
IL-4 is known to present abnormal expression in thyroid tumors and SNPs in the
IL-4
and its receptor
IL-4R
genes are associated to risk and mortality of various types of cancer.
Methods
In order to evaluate their role in differentiated thyroid cancer (DTC), we investigated genetic frequencies of two
IL-4
promoter SNPs (rs2070874 C>T, rs2243250 C>T) and four non-synonymous SNPs of the
IL-4R
gene (rs1805010 A>G, rs1805012 C>T, rs1805013 C>T, rs1801275 A>G) in 300 DTC patients matched to 300 controls. All patients were managed according to current guidelines and followed-up for a period of 12–252 months (69.20 ± 52.70 months).
Results
Although none of the six investigated SNPs showed association with risk of DTC, rs1805010 was associated with age of diagnosis and the SNPs rs1805012 and rs1801275 were associated to gender. Further, in-silico analysis showed that all these three SNPs were able to cause decreased stability of the protein. We were not able to demonstrate any other association to clinical features of aggressiveness or to patients’ prognosis.
Conclusions
These findings indicate that although genetic variants in
IL-4
and
IL-4R
do not influence the risk or outcome of DTC patients, their influence on the behavior of thyroid tumors deserves further investigation. |
---|---|
ISSN: | 1355-008X 1559-0100 |
DOI: | 10.1007/s12020-020-02486-z |